Sorafenib-Induced Eruption Mimicking Erythema Multiforme.
作者信息
Pichard Dominique C, Cardones Adela R, Chu Emily Y, Dahut William L, Kong Heidi H
机构信息
Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Department of Dermatology, Duke University Medical Center, Durham, North Carolina.
出版信息
JAMA Dermatol. 2016 Feb;152(2):227-8. doi: 10.1001/jamadermatol.2015.2930.
Abstract
摘要
相似文献
1
Sorafenib-Induced Eruption Mimicking Erythema Multiforme.
JAMA Dermatol. 2016 Feb;152(2):227-8. doi: 10.1001/jamadermatol.2015.2930.
2
Sorafenib-associated psoriasiform eruption in a patient with hepatocellular carcinoma.
J Drugs Dermatol. 2014 Aug;13(8):899-900.
3
Grade III hand-foot skin reaction induced by sorafenib.
An Bras Dermatol. 2017 Jul-Aug;92(4):590-591. doi: 10.1590/abd1806-4841.20176631.
4
Perforating folliculitis-like reaction related to sorafenib.
Cutis. 2014 Jan;93(1):E8-10.
5
Delayed onset perforating folliculitis associated with sorafenib.
Australas J Dermatol. 2014 Aug;55(3):233-5. doi: 10.1111/ajd.12207.
6
[Two cases of successful sorafenib retreatment with the addition of steroid therapy following sorafenib-induced erythema multiforme in two patients with hepatocellular carcinoma].
Nihon Shokakibyo Gakkai Zasshi. 2014 Jul;111(7):1424-32.
7
Sorafenib-induced annular pustular psoriasis (Milian-Katchoura type).
Eur J Dermatol. 2013 Nov-Dec;23(6):900-1. doi: 10.1684/ejd.2013.2184.
8
Sorafenib induced eruptive melanocytic lesions.
Dermatol Online J. 2013 May 15;19(5):18184.
9
Tolerability of single-agent sorafenib in the treatment of elderly patients with hepatocellular carcinoma (HCC).
Hepatology. 2014 Aug;60(2):764-5. doi: 10.1002/hep.26921.
10
Acne inversa-like lesions associated with the multi-kinase inhibitor sorafenib.
Clin Exp Dermatol. 2014 Mar;39(2):232-3. doi: 10.1111/ced.12257. Epub 2013 Dec 12.
引用本文的文献
1
Sorafenib-Induced Erythema Multiforme Major and Severe Hepatic Failure in Metastatic Hepatocellular Carcinoma: A Case Report.
Cureus. 2024 Mar 29;16(3):e57179. doi: 10.7759/cureus.57179. eCollection 2024 Mar.
2
Atypical Targetoid Eruption Induced by Sorafenib in a Patient with Hepatocellular Carcinoma.
Indian J Dermatol. 2020 Mar-Apr;65(2):158-160. doi: 10.4103/ijd.IJD_581_18.
本文引用的文献
1
Erythema multiforme induced by sorafenib for metastatic renal cell carcinoma.
Jpn J Clin Oncol. 2012 Sep;42(9):820-4. doi: 10.1093/jjco/hys103. Epub 2012 Jul 10.
2
Sorafenib-induced erythema multiforme: three cases.
Eur J Dermatol. 2011 Nov-Dec;21(6):1015-6. doi: 10.1684/ejd.2011.1535.
3
Sorafenib-induced erythema multiforme for metastatic renal cell carcinoma.
Ann Oncol. 2010 Jul;21(7):1563-1565. doi: 10.1093/annonc/mdq299.
4
Sorafenib-induced erythema multiforme in metastatic renal cell carcinoma.
Cutan Ocul Toxicol. 2009;28(2):90-2. doi: 10.1080/15569520902915469.
5
Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor.
Arch Dermatol. 2008 Jul;144(7):886-92. doi: 10.1001/archderm.144.7.886.
6
Sorafenib-induced erythema multiforme.
J Am Acad Dermatol. 2007 Mar;56(3):527-8. doi: 10.1016/j.jaad.2006.10.981. Epub 2007 Jan 22.
Zotero 插件